表紙
市場調査レポート

橋本病:世界の治験レビュー

Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 318336
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
橋本病:世界の治験レビュー Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014
出版日: 2014年10月31日 ページ情報: 英文 58 Pages
概要

橋本病(橋本甲状腺炎)は、甲状腺、すなわち喉仏下の首の付け根にある小さな腺を、免疫系が攻撃している状態です。甲状腺は、内分泌系の一部で、体の活動の多くを調整するホルモンを生成します。橋本病による炎症は、慢性リンパ球性甲状腺炎としても知られ、多くは甲状腺機能の低下(甲状腺機能低下症)をもたらします。橋本病は、米国における甲状腺機能低下症の最大の原因です。主に中年女性に見られますが、男性、あらゆる年齢の女性、子供にも生じる可能性があります。医師は、甲状腺機能を検査することで、橋本病の判定ができます。橋本病では、通常、甲状腺ホルモン補充療法が行われ、簡単かつ効果的です。

当レポートでは、橋本病の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカ

G7諸国における治験:免疫系の治験に対する橋本病の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:免疫系の治験に対する橋本病の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 橋本病の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • Rock Creek Pharmaceuticals INC
    • Cefak KG
  • 主要大学・研究機関・病院の治験概要
    • National Taiwan University Hospital
    • China Medical University
    • University of Colorado Denver
    • Tabriz University of Medical Sciences
    • The Polish Committee of Scientific Research
    • Taipei Medical University WanFang Hospital
    • Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
    • Sapienza University of Rome
    • University of Texas Medical Branch at Galveston
    • Ege University

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2381CTIDB

GlobalData's clinical trial report, "Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014" provides data on the Hashimoto's Thyroiditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hashimoto's Thyroiditis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hashimoto's Thyroiditis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hashimoto's Thyroiditis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hashimoto's Thyroiditis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Rock Creek Pharmaceuticals INC
      • Clinical Trial Overview of Rock Creek Pharmaceuticals INC
      • Cefak KG
      • Clinical Trial Overview of Cefak KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • China Medical University
      • Clinical Trial Overview of China Medical University
      • University of Colorado Denver
      • Clinical Trial Overview of University of Colorado Denver
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • The Polish Committee of Scientific Research
      • Clinical Trial Overview of The Polish Committee of Scientific Research
      • Taipei Medical University WanFang Hospital
      • Clinical Trial Overview of Taipei Medical University WanFang Hospital
      • Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
      • Clinical Trial Overview of Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
      • Sapienza University of Rome
      • Clinical Trial Overview of Sapienza University of Rome
      • University of Texas Medical Branch at Galveston
      • Clinical Trial Overview of University of Texas Medical Branch at Galveston
      • Ege University
      • Clinical Trial Overview of Ege University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hashimoto's Thyroiditis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cefak KG, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Polish Committee of Scientific Research, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Medical Branch at Galveston, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ege University, 2014*

List of Figures

  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hashimoto's Thyroiditis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top